These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 287040)

  • 1. Protective effect of immunization with nonviral antigens against Friend leukemia virus in mice.
    Nahon-Merlin E; Lacour F; Friend C; Revoltella R
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2018-21. PubMed ID: 287040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of immunization with polyinosinic-polycytidylic acid complexed with methylated bovine serum albumin against Friend leukemia virus in mice.
    Fourcade A; Friend C; Lacour F; Holland JG
    Cancer Res; 1974 Jul; 34(7):1749-51. PubMed ID: 4833920
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum.
    Hunsmann G; Moennig V; Schäfer W
    Virology; 1975 Jul; 66(1):327-9. PubMed ID: 1136142
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protection of mice against Friend leukemia by active and passive immunization with isolated viral glycoprotein and its antiserum respectively (author's transl)].
    Hunsmann G; Moennig V; Seifert E; Schäfer W
    Z Naturforsch C Biosci; 1975; 30(2):309-10. PubMed ID: 125981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.
    Miyazawa M; Fujisawa R; Ishihara C; Takei YA; Shimizu T; Uenishi H; Yamagishi H; Kuribayashi K
    J Immunol; 1995 Jul; 155(2):748-58. PubMed ID: 7541823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
    Pettey CL; Collins JJ
    Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F; Genovesi EV; Collins JJ
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
    Genovesi EV; Collins JJ
    J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
    Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
    J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spontaneous leukemia of AKR mice. Successful passive immunization with goat antibodies against isolated glycoprotein gp71 of Friend leukemia virus].
    Schwarz H; Thiel HJ; Schäfer W
    Z Naturforsch C Biosci; 1977; 32(5-6):459-61. PubMed ID: 141818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprevention of Friend leukaemia virus-induced erythroleukaemia by vaccination with aggregated gp70.
    Kleiser C; Schneider J; Bayer H; Hunsmann G
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1901-7. PubMed ID: 2427646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.
    Collins JJ; Sackie DM; Johnson GR
    Virology; 1983 Apr; 126(1):259-66. PubMed ID: 6573816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus.
    Ruan KS; Lilly F
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12202-6. PubMed ID: 1465459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of murine immune response to nucleic acids.
    Fuchs S; Mozes E; Stollar BD
    J Immunol; 1975 Apr; 114(4):1287-91. PubMed ID: 1117141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprotective determinants in friend murine leukemia virus envelope protein.
    Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
    Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Friend-associated lymphatic leukemia virus in immunization against Friend leukemia complex.
    Bendinelli M
    Experientia; 1977 Apr; 33(4):455-6. PubMed ID: 862726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D; Tsuji-Kawahara S; Miyazawa M
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.